Article
Eli Lilly boosts immunology business with $2.4 billion deal for Dice
Rating:
0.0
Views:
29
Likes:
1
Library:
1
Eli Lilly and Co will buy Dice Therapeutics Inc for about $2.4 billion in cash, the company said on Tuesday, bolstering its immune disease-related portfolio with an experimental pill to treat psoriasis.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value